122 related articles for article (PubMed ID: 32776520)
1. Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital.
Chertack N; Ghandour RA; Singla N; Freifeld Y; Hutchinson RC; Courtney K; Bowman IA; Arafat W; Meng X; Moore JA; Aydin AM; Sagalowsky AI; Margulis V; Lotan Y; Woldu SL; Bagrodia A
Cancer; 2020 Oct; 126(19):4362-4370. PubMed ID: 32776520
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
[TBL] [Abstract][Full Text] [Related]
3. Colorectal Cancer Safety Net: Is It Catching Patients Appropriately?
Althans AR; Brady JT; Times ML; Keller DS; Harvey AR; Kelly ME; Patel ND; Steele SR
Dis Colon Rectum; 2018 Jan; 61(1):115-123. PubMed ID: 29219921
[TBL] [Abstract][Full Text] [Related]
4. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
5. Disparities in Pre-Orchiectomy Sperm Cryopreservation Among Testicular Cancer Patients at a Public Safety Net Hospital and a Private Tertiary Care Center.
Patel A; Howard JM; Chertack N; Badia RR; Margulis V; Woldu SL; Courtney K; Bowman IA; Arafat W; Meng X; Bakare T; Bagrodia A
Urology; 2022 May; 163():126-131. PubMed ID: 34343562
[TBL] [Abstract][Full Text] [Related]
6. The Significance of Spermatic Cord Involvement by Testicular Germ Cell Tumors: Should We Be Staging Discontinuous Invasion From Involved Lymphovascular Spaces Differently From Direct Extension?
Sanfrancesco JM; Trevino KE; Xu H; Ulbright TM; Idrees MT
Am J Surg Pathol; 2018 Mar; 42(3):306-311. PubMed ID: 29309304
[TBL] [Abstract][Full Text] [Related]
7. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
[TBL] [Abstract][Full Text] [Related]
9. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
10. Racial and socioeconomic disparities in retroperitoneal lymph node dissection and survival in nonseminomatous germ cell tumor: A population-based study.
Bhambhvani HP; Greenberg DR; Kasman AM; DeRouen MC; Cheng I; Eisenberg ML; Shah SA
Urol Oncol; 2021 Mar; 39(3):197.e1-197.e8. PubMed ID: 33423934
[TBL] [Abstract][Full Text] [Related]
11. Nationwide Patterns of Care for Stage II Nonseminomatous Germ Cell Tumor of the Testicle.
Ghandour R; Ashbrook C; Freifeld Y; Singla N; El-Asmar JM; Lotan Y; Margulis V; Eggener S; Woldu S; Bagrodia A
Eur Urol Oncol; 2020 Apr; 3(2):198-206. PubMed ID: 31272940
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
[TBL] [Abstract][Full Text] [Related]
13. Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer.
Williams SB; Kacker R; Winston D; Bahnson E; Steele GS; Richie JP
J Urol; 2011 Dec; 186(6):2245-8. PubMed ID: 22014805
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium.
Shaikh F; Stark D; Fonseca A; Dang H; Xia C; Krailo M; Pashankar F; Rodriguez-Galindo C; Olson TA; Nicholson JC; Murray MJ; Amatruda JF; Billmire D; Stoneham S; Frazier AL
Cancer; 2021 Jan; 127(2):193-202. PubMed ID: 33079404
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of diagnostic delay and effect on treatment patterns in testicular germ cell tumor patients.
Badia RR; Chertack N; Meng X; Howard J; Singla N; Margulis V; Lotan Y; Woldu S; Bagrodia A
Urol Oncol; 2022 May; 40(5):201.e1-201.e7. PubMed ID: 35400569
[TBL] [Abstract][Full Text] [Related]
16. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
[TBL] [Abstract][Full Text] [Related]
18. A comparison of stage-specific all-cause mortality between testicular sex cord stromal tumors and germ cell tumors: results from the National Cancer Database.
Zuniga KB; Washington SL; Porten SP; Meng MV
BMC Urol; 2020 Apr; 20(1):40. PubMed ID: 32303266
[TBL] [Abstract][Full Text] [Related]
19. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
Williams SB; Steele GS; Richie JP
J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
[TBL] [Abstract][Full Text] [Related]
20. Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.
Howard SA; Gray KP; O'Donnell EK; Fennessy FM; Beard CJ; Sweeney CJ
AJR Am J Roentgenol; 2014 Oct; 203(4):W415-20. PubMed ID: 25247970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
